276 related articles for article (PubMed ID: 14966832)
41. Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy.
Cole PD; Zebala JA; Alcaraz MJ; Smith AK; Tan J; Kamen BA
Cancer Chemother Pharmacol; 2006 Jun; 57(6):826-34. PubMed ID: 16170572
[TBL] [Abstract][Full Text] [Related]
42. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia.
Aytaç S; Yetgin S; Tavil B
Turk J Pediatr; 2006; 48(1):1-7. PubMed ID: 16562778
[TBL] [Abstract][Full Text] [Related]
43. [Assessment of elimination and tolerance of high dose of methotrexate (3 g/m2) in children with standard-risk acute lymphoblastic leukemia].
Cwliklińska M; Balwierz W; Nowak J; Stanuch H
Przegl Lek; 2006; 63(1):15-20. PubMed ID: 16892893
[TBL] [Abstract][Full Text] [Related]
44. Cerebrospinal fluid lactic dehydrogenase activity in children with acute lymphoblastic leukemia treated for cranial prophylaxis.
Caglar MK; Hicsonmez G; Renda N
Paediatr Indones; 1989; 29(5-6):112-5. PubMed ID: 2812823
[TBL] [Abstract][Full Text] [Related]
45. Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma.
Gerber DE; Grossman SA; Batchelor T; Ye X
Cancer Chemother Pharmacol; 2007 May; 59(6):817-23. PubMed ID: 16972068
[TBL] [Abstract][Full Text] [Related]
46. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
Bleyer WA; Dedrick RL
Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
[TBL] [Abstract][Full Text] [Related]
47. Evidence for negative feedback of extracellular methotrexate on blasts of acute lymphoblastic leukemia in vitro.
Hum MC; Smith AK; Lark RH; Winick NJ; Kamen BA
Pharmacotherapy; 1997; 17(6):1260-6. PubMed ID: 9399609
[TBL] [Abstract][Full Text] [Related]
48. [Cytological findings of the cerebrospinal fluid at diagnosis of acute lymphocytic leukemia in children--effect of remission induction chemotherapy].
Kinumaki H; Bessho F; Yokota S
Rinsho Ketsueki; 1989 Oct; 30(10):1763-8. PubMed ID: 2593242
[TBL] [Abstract][Full Text] [Related]
49. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
[TBL] [Abstract][Full Text] [Related]
50. [Adverse effects of methotrexate in the treatment of acute lymphoblastic leukemia in Uyghur and Han children].
Hu WW; Nuriding H; Yan M
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Nov; 14(11):852-5. PubMed ID: 23146734
[TBL] [Abstract][Full Text] [Related]
51. Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy.
Peng CT; Wu KH; Lan SJ; Tsai JJ; Tsai FJ; Tsai CH
Eur J Cancer; 2005 May; 41(8):1158-63. PubMed ID: 15911239
[TBL] [Abstract][Full Text] [Related]
52. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
53. Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions.
Broxson EH; Stork LC; Allen RH; Stabler SP; Kolhouse JF
Cancer Res; 1989 Nov; 49(21):5879-83. PubMed ID: 2790801
[TBL] [Abstract][Full Text] [Related]
54. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
[TBL] [Abstract][Full Text] [Related]
55. Beta-glucuronidase in the diagnosis of bacterial meningitis and response to treatment.
Beratis NG; Eliopoulou MI; Syrogiannopoulos GA
Acta Paediatr; 2003 Nov; 92(11):1272-6. PubMed ID: 14696846
[TBL] [Abstract][Full Text] [Related]
56. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
57. [New aspects of the determination of blood methotrexate levels in leukemic children].
Schuler D; Borsi J; Koós R; Révész T; Kardos G; Somló P
Monatsschr Kinderheilkd; 1986 Oct; 134(10):765-8. PubMed ID: 3467178
[TBL] [Abstract][Full Text] [Related]
58. Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.
Li Y; Vijayanathan V; Gulinello M; Cole PD
Pharmacol Biochem Behav; 2010 Jun; 95(4):428-33. PubMed ID: 20332001
[TBL] [Abstract][Full Text] [Related]
59. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.
Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ
Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718
[TBL] [Abstract][Full Text] [Related]
60. Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay.
Lingg RM; Hempel G; Rots MG; Van Zantwijk CH; Boos J; Kaspers GJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):322-7. PubMed ID: 15868145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
